ReviewNature cancer2025
The rapidly evolving paradigm of neoadjuvant immunotherapy across cancer types.
Gil Awada et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
24 papers cite it
this paperpooled itcites it
ReviewNature cancer2025
Gil Awada et al.PubMed ↗Publisher ↗
No numbers read from the abstract.